Merck & Co. Stock Hits Day High with Strong Intraday Performance

Merck & Co., Inc. has experienced a notable uptick in its stock performance, gaining 3.79% on February 27, 2026. The stock reached an intraday high of USD 123.99, reflecting strong market activity. In comparison to the S&P 500, which saw a decline of 0.43% on the same day, Merck's performance stands out, showcasing its resilience in the current market environment. Over the past month, Merck has demonstrated a robust increase of 14.73%, significantly outperforming the S&P 500's decline of 1.43%. Year-to-date, the company has achieved a gain of 17.63%, while the S&P 500 has only managed a modest 0.49% increase. Additionally, Merck's one-year performance shows a substantial rise of 36.7%, compared to the S&P 500's 17.36%. The company maintains a strong financial position, highlighted by a high return on capital employed (ROCE) of 22.52% and a low debt-to-EBITDA ratio of 1.58 times. With positive results reported for the last four consecutive quarters, Merck continues to demonstrate its operational strength within the pharmaceuticals and biotechnology industry.